Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 22633182)


The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA; National Heart Lung Blood Institute Retrovirus Epidemiology Donor Study; Retrovirus Epidemiology Donor Study-II.

Transfus Med Rev. 2012 Oct;26(4):281-304, 304.e1-2. doi: 10.1016/j.tmrv.2012.04.004. Epub 2012 May 24.


Contribution of the Retrovirus Epidemiology Donor Study (REDS) to research on blood transfusion safety in Brazil.

Loureiro P, de Almeida-Neto C, Proietti AB, Capuani L, Gonçalez TT, de Oliveira CD, Leão SC, Lopes MI, Sampaio D, Patavino GM, Ferreira JE, Blatyta PF, Lopes ME, Mendrone-Junior A, Salles NA, King M, Murphy E, Busch M, Custer B, Sabino EC.

Rev Bras Hematol Hemoter. 2014 Mar;36(2):152-8. doi: 10.5581/1516-8484.20140033.


The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes.

Kleinman S, Busch MP, Murphy EL, Shan H, Ness P, Glynn SA; National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Transfusion. 2014 Mar;54(3 Pt 2):942-55. doi: 10.1111/trf.12468. Epub 2013 Nov 4.


Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE.

JAMA. 2000 Jul 12;284(2):229-35.


The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.

Kleinman SH, Glynn SA, Higgins MJ, Triulzi DJ, Smith JW, Nass CC, Garratty G, Murphy EL, LeParc GF, Schreiber GB, King MR, Chamberland ME, Nemo GJ.

Transfusion. 2005 Jul;45(7):1073-83.


Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil.

Sabino EC, Gonçalez TT, Carneiro-Proietti AB, Sarr M, Ferreira JE, Sampaio DA, Salles NA, Wright DJ, Custer B, Busch M; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component.

Transfusion. 2012 Apr;52(4):870-9. doi: 10.1111/j.1537-2995.2011.03344.x. Epub 2011 Oct 7.


Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study.

Korelitz JJ, Williams AE, Busch MP, Zuck TF, Ownby HE, Matijas LJ, Wright DJ.

Transfusion. 1994 Oct;34(10):870-6.


Seroprevalence of xenotropic murine leukemia virus-related virus in normal and retrovirus-infected blood donors.

Qiu X, Swanson P, Tang N, Leckie GW, Devare SG, Schochetman G, Hackett J Jr.

Transfusion. 2012 Feb;52(2):307-16. doi: 10.1111/j.1537-2995.2011.03395.x. Epub 2011 Oct 24.


Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.

Zou S, Musavi F, Notari EP 4th, Fujii KE, Dodd RY; ARCNET Study Group.

Transfusion. 2005 Oct;45(10):1593-600.


Transfusion recipient epidemiology and outcomes research: possibilities for the future.

Hillyer CD, Blumberg N, Glynn SA, Ness PM; NHLBI Working Group in Transfusion Recipient Epidemiology and Outcomes Research.

Transfusion. 2008 Aug;48(8):1530-7. doi: 10.1111/j.1537-2995.2008.01807.x. Epub 2008 Jun 28.


Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety.

Dodd RY, Hackett J Jr, Linnen JM, Dorsey K, Wu Y, Zou S, Qiu X, Swanson P, Schochetman G, Gao K, Carrick JM, Krysztof DE, Stramer SL.

Transfusion. 2012 Feb;52(2):298-306. doi: 10.1111/j.1537-2995.2011.03450.x. Epub 2011 Nov 21.


Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study.

Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, Kleinman SH, Hollingsworth CG, Nemo GJ.

JAMA. 1997 Mar 26;277(12):967-72.


Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study.

Schreiber GB, Murphy EL, Horton JA, Wright DJ, Garfein R, Chien HC, Nass CC.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):263-71.


Biospecimen repositories: are blood donors willing to participate?

Scott EA, Schlumpf KS, Mathew SM, Mast AE, Busch MP, Gottschall JL; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2010 Sep;50(9):1943-50. doi: 10.1111/j.1537-2995.2010.02667.x.


Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.

Nelson KE, Donahue JG, Muñoz A, Cohen ND, Ness PM, Teague A, Stambolis VA, Yawn DH, Callicott B, McAllister H, et al.

Ann Intern Med. 1992 Oct 1;117(7):554-9.


Emerging viral infections‑-a potential threat for blood supply in the 21st century.

de Mendoza C, Altisent C, Aznar JA, Batlle J, Soriano V.

AIDS Rev. 2012 Oct-Dec;14(4):279-89. Review.


Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period.

Custer B, Schlumpf K, Simon TL, Spencer BR, Wright DJ, Wilkinson SL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2012 Apr;52(4):712-21. doi: 10.1111/j.1537-2995.2011.03353.x. Epub 2011 Sep 26.


Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.

Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ.

J Infect Dis. 1997 Dec;176(6):1468-75.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk